Trial Outcomes & Findings for Endorail in Long Lasting Colonoscopy (NCT NCT05626738)
NCT ID: NCT05626738
Last Updated: 2024-09-19
Results Overview
Colonoscopy is defined completed when caecal intubation is achieved. Colonoscopy is defined long-lasting when caecal intubation time is longer than 10 minutes. The percentage of incomplete long-lasting colonscopies is calculated as the ratio, in percetange, between the number of incomplete long-lasting colonscopies and the total number of patients enrolled.
COMPLETED
NA
38 participants
day 1
2024-09-19
Participant Flow
Trial Initiation Date: 25 January 2023 Trial Completion Date: 25 July 2023 Coordinating / Principal Investigator: * IRCCS Humanitas Research Hospital, Via Manzoni 56, I-20089 Rozzano (Milan, Italy). PI: Prof. Alessandro Repici. * GastroZentrum Lippe, Lange Str.55, Bad Salzuflen (Germany). PI: Prof. Helmut Neumann * University Hospitals Leuven. Herestraat 49, B-3000 Leuven (Belgium). PI: Prof. Raf Bisschops
Participant milestones
| Measure |
Long-lasting Colonoscopy With Endorail
In case of long-lasting colonoscopy, Endorail is used to facilitate the completion of the procedure.
|
|---|---|
|
Overall Study
STARTED
|
38
|
|
Overall Study
COMPLETED
|
38
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Long-lasting Colonoscopy With Endorail
n=38 Participants
In case of long-lasting colonoscopy, Endorail is used to facilitate the completion of the procedure.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=38 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
38 Participants
n=38 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=38 Participants
|
|
Age, Continuous
|
57.7 years
STANDARD_DEVIATION 10.1 • n=38 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=38 Participants
|
|
Sex: Female, Male
Male
|
19 Participants
n=38 Participants
|
|
Region of Enrollment
Belgium
|
2 participants
n=38 Participants
|
|
Region of Enrollment
Italy
|
21 participants
n=38 Participants
|
|
Region of Enrollment
Germany
|
15 participants
n=38 Participants
|
PRIMARY outcome
Timeframe: day 1Colonoscopy is defined completed when caecal intubation is achieved. Colonoscopy is defined long-lasting when caecal intubation time is longer than 10 minutes. The percentage of incomplete long-lasting colonscopies is calculated as the ratio, in percetange, between the number of incomplete long-lasting colonscopies and the total number of patients enrolled.
Outcome measures
| Measure |
Long-lasting Colonoscopy With Endorail
n=38 Participants
In case of long-lasting colonoscopy, Endorail is used to facilitate the completion of the procedure.
|
|---|---|
|
Percentage of Incomplete Long-lasting Colonscopies
|
0 % of participants
|
PRIMARY outcome
Timeframe: day 1Number of the device-related serious adverse events collected at day 1 visit
Outcome measures
| Measure |
Long-lasting Colonoscopy With Endorail
n=38 Participants
In case of long-lasting colonoscopy, Endorail is used to facilitate the completion of the procedure.
|
|---|---|
|
Number of Device-related Serious Adverse Events
|
0 Number of Device-related SAE
|
PRIMARY outcome
Timeframe: day 7Number of device-related serious adverse events collected through phone call at day 7.
Outcome measures
| Measure |
Long-lasting Colonoscopy With Endorail
n=36 Participants
In case of long-lasting colonoscopy, Endorail is used to facilitate the completion of the procedure.
|
|---|---|
|
Number of Device-related Serious Adverse Events
|
0 Number of Device-related SAE
|
Adverse Events
Long-lasting Colonoscopy With Endorail
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Long-lasting Colonoscopy With Endorail
n=38 participants at risk
In case of long-lasting colonoscopy, Endorail is used to facilitate the completion of the procedure.
|
|---|---|
|
Gastrointestinal disorders
Hypogastric pain
|
2.6%
1/38 • Number of events 1 • 7 days
|
|
Gastrointestinal disorders
Hemorroidal plexus infiam-mation
|
2.6%
1/38 • Number of events 1 • 7 days
|
|
General disorders
Seasonal allergy
|
2.6%
1/38 • Number of events 1 • 7 days
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place